With over 30 years of clinical excellence in MS, Biogen is a leader in multiple sclerosis (MS) research. Biogen continues its commitment to patients through ongoing research, solutions and services to support unmet needs in the management of MS. Biogen currently has the broadest MS portfolio in the industry with products that help treat across the spectrum of relapsing forms of MS. Through affordability programs, we are committed to continuing to improve access to products for patients who need them.

To access these and other services provided by the Biogen ONE™ Support Program, please follow this link.

For more information on Multiple Sclerosis, please visit www.biogencareforms.ca

PLEGRIDY™ (peginterferon beta-1a)